Amy Tobin, DO
Endocrinology, Diabetes & Metabolism · Sterling Heights, MINPI 1093743007
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $31,944 of the $36,529 with a category attached, or 87.4%. It is spread thinly across 60 manufacturers, the largest accounting for just 18.3% — the pattern of someone who eats at a lot of different presentations. Among endocrinology, diabetes & metabolism clinicians in MI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 1,130 payments — averaging $32.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$7K
- Novo Nordisk$4K
- Amgen$3K
- Abbott$3K
- Cequr Corporation$2K
- Lilly USA, LLC$2K
- plus $16K from 54 others
What the payments were for
- Consulting fees$1,0503%
- Travel & lodging$3,3169%
- Food & beverage$31,94487%
- Education$2201%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CeQur Simplicity$2,436
- EVENITY$1,312
- Minimed 670G System$1,248
- FreeStyle Libre Pro$1,150
- MINIMED 780G$1,135
- Prolia$955
- FARXIGA$880
- MINIMED 770G$707
- t-slim insulin pump$669
- INPEN SMART INSULIN DELIVERY SYSTEM$627
- Wegovy$462
- DEXCOM G6 TRANSMITTER$410
- Ozempic$409
- TEPEZZA$361
- MOUNJARO$358
- JATENZO$352
- AFREZZA$330
- Tresiba$313
- FREESTYLE LIBRE 3$285
- FreeStyle Libre$261
How this compares
$36,529 in reported general payments places this provider in the 90th percentile of 219 endocrinology, diabetes & metabolism providers in Michigan.
See all endocrinology, diabetes & metabolism providers in Michigan →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 180 | $373,704 |
| JardianceEmpagliflozin | 197 | $272,818 |
| MounjaroTirzepatide | 144 | $261,627 |
| TrulicityDulaglutide | 87 | $153,160 |
| FarxigaDapagliflozin Propanediol | 76 | $96,907 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 18 | $33,247 |
| Tresiba Flextouch U-100Insulin Degludec | 48 | $31,927 |
| JanuviaSitagliptin Phosphate | 20 | $23,758 |
| Cequr SimplicityBolus Insulin Pump, 200 Unit | 23 | $23,198 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 22 | $19,669 |
| Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/7 | 24 | $18,531 |
| Tresiba Flextouch U-200Insulin Degludec | 14 | $15,249 |
| Novolog FlexpenInsulin Aspart | 63 | $13,847 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 74 | $11,448 |
| Nano 2nd Gen Pen NeedlePen Needle, Diabetic | 78 | $8,497 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $2,120 | $414,787231 claims |
| Novo NordiskOzempic, Novolog | $3,627 | $378,571196 claims |
| Boehringer IngelheimJardiance | $391 | $272,818197 claims |
| AstraZenecaFarxiga | $1,912 | $96,90776 claims |
| MerckJanuvia | $255 | $23,75820 claims |
| Cequr CorporationCequr Simplicity | $2,443 | $23,19823 claims |
| Amneal Pharmaceuticals LLCUnithroid, Levothyroxine Sodium | $315 | $3,666236 claims |
| AbbVieSynthroid | $609 | $2,00315 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 219 endocrinology, diabetes & metabolism providers in Michigan.
Other endocrinology, diabetes & metabolism in Sterling Heights
- Eric LangerSterling Heights$213K
- Nancy AndrewsSterling Heights$20K
- Lowell SchmeltzFarmington Hills$1.3M
- George GrunbergerBloomfield Hills$931K
- Gary EdelsonFarmington Hills$503K
- Michael BrennanSaint Clair Shores$433K
- Jamal HammoudFlint$386K
- Abdulsalam Al KassabRochester Hills$351K
- Richard AuchusAnn Arbor$250K
- Ashish VermaShelby Twp$179K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.